Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
228 USD | -1.99% | -1.72% | +10.91% |
08/06 | Top law firms in US opioid lawsuits to get hundreds of millions in fees | RE |
03/06 | Cencora Insider Sold Shares Worth $419,506, According to a Recent SEC Filing | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- The company shows low valuation levels, with an enterprise value at 0.16 times its sales.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- The company appears highly valued given the size of its balance sheet.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+10.91% | 4.58TCr | B- | ||
-4.76% | 18TCr | C+ | ||
+0.27% | 11TCr | C | ||
-3.67% | 6.79TCr | A | ||
-5.38% | 4.65TCr | B- | ||
+6.38% | 4.25TCr | B+ | ||
+19.42% | 3.08TCr | B | ||
+16.53% | 2.61TCr | A- | ||
-3.80% | 2.39TCr | A- | ||
-10.91% | 2.25TCr | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- COR Stock
- Ratings Cencora, Inc.